The Schall Law Firm Encourages Shareholders To Join A Securities Fraud Case Against Allarity Therapeutics, Inc.Accesswire • 10/24/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Allarity Therapeutics, Inc. to Contact the Firm Today!Accesswire • 10/23/24
Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for StenoparibGlobeNewsWire • 10/22/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/22/24
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allarity Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALLRAccesswire • 10/21/24
RLF, TRUSTED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 10/20/24
Allarity Therapeutics, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Allarity Therapeutics, Inc.GlobeNewsWire • 10/18/24
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 10/17/24
Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Urged To Contact The Schall Law FirmAccesswire • 10/17/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Allarity Therapeutics, Inc. to Contact the Firm Today!Accesswire • 10/16/24
Allarity Therapeutics, Inc Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Allarity Therapeutics, Inc.PRNewsWire • 10/15/24
ALLR Stockholders Have Opportunity to Lead Allarity Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • 10/14/24
ALLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/13/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/11/24
ROSEN, A LEADING NATIONAL FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 10/10/24
Allarity Therapeutics, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Allarity Therapeutics, Inc.GlobeNewsWire • 10/10/24
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price RequirementGlobeNewsWire • 10/10/24
ALLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/09/24
Allarity Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Assist The Schall Law FirmAccesswire • 10/09/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/08/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/07/24
Allarity Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law FirmAccesswire • 10/06/24
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 10/06/24
Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor ProgramGlobeNewsWire • 10/03/24
ALLR Shareholders With Large Losses Should Contact Robbins LLP for Information About the Allarity Therapeutics, Inc. Securities Class ActionAccesswire • 10/02/24
